Monod Bio

📍 Seattle, United States🗓 Founded 2021👥 32 employees💰 Last funded Jul 2022
Biotechnology Research
LinkedIn
Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays. Our visionary founding team and state-of-the-art technology position Monod Bio at the forefront of biosensor innovation, and we welcome exceptional individuals to join us in this journey.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Monod Bio?
Monod Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Monod Bio last raise funding?
The most recent investment in Monod Bio recorded on gritt.io was in July 2022.
When was Monod Bio founded?
Monod Bio was founded in 2021.
What industry is Monod Bio in?
Monod Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Monod Bio based?
Monod Bio is headquartered in Seattle, United States.